Remove 2023 Remove Cannabis Remove Compliance Remove Safety
article thumbnail

Update to Public Health and Safety Bulletin 2023-01 Update Issued February 9, 2023

Cannabis Law Report

On January 19, 2023, the Nevada Cannabis Compliance Board (CCB) issued Public Health and Safety Bulletin 2023-01 after CCB Board Agents discovered nearly 8,000 pounds of cannabis and cannabis products had been treated with the unapproved pesticide, Ethephon. As a result, the product list […]

Safety 52
article thumbnail

Public Health and Safety Bulletin 2023-01 “avoid or take caution when consuming -All usable cannabis harvested by Clark Natural Medicinal Solutions, LLC”

Cannabis Law Report

Public Health and Safety Bulletin 2023-01 The Nevada Cannabis Compliance Board (CCB) is hereby issuing Public Health and Safety Bulletin 2023-01 on January 19, 2023 advising consumers and patients to avoid or take caution when consuming the cannabis products which are the subject of this notice.

Safety 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Latest in Multi-Jurisdictional Marijuana Compliance

Cannabis Law Report

This comes as respondents to Ogletree Deakins’ recent survey report, Strategies and Benchmarks for the Workplace: Ogletree’s Survey of Key Decision-Makers , indicated that keeping up with marijuana laws is already one of the most challenging areas of multi-jurisdictional compliance for employers. That is beginning to change.

article thumbnail

The Week in Weed: November 4, 2022

The Blunt Truth

This week, we start off in Nevada, where a judge determined that marijuana should no longer appear on the state’s Schedule I, and where a lot of people would like to open cannabis lounges. Then we travel to Mississippi, where medical marijuana sales will begin in January 2023. NEVADA RESCHEDULING. MISSISSIPPI.

Safety 111
article thumbnail

Should the Cannabis Industry Be Concerned About Endotoxins?

Medicinal Genomics

Employees in cannabis production facilities are exposed to large quantities of ground product, which may trigger asthma, allergic rhinitis, and urticaria. In November 2023, the CDC reported a fatal occupational asthma attack suffered by an employee at a Massachusetts cannabis production facility. This piqued our interest.

article thumbnail

NCIA Event, June 13: Paul Coble Moderates Panel on Testing and Labeling for “Minor Cannabinoid” Products

Canna Law Blog

We are pleased to announce Paul Coble as a panelist moderator for the National Cannabis Industry Association (NCIA) webinar event this coming Tuesday, Jun 13, 2023 at 12:00 PM. Paul is an intellectual property attorney and software startup founder with a deep background in cannabis science and technology.

Events 72
article thumbnail

Oregon Cannabis Investigation Serves As a Reminder About Consumer Product Safety

Cannabis Law Report

The Oregon Liquor and Cannabis Commission (OLCC) is conducting an ongoing investigation into Curaleaf regarding an alleged mislabeling of a nonpsychoactive cannabidiol (CBD) product, which actually contained psychoactive delta-9 tetrahydracannabinol (THC). Curaleaf operates 101 retail cannabis dispensaries in 16 states.